---
schema_version: "secwatch.filing_event.v1"
accession: "0000926617-22-000069"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2022-12-21T23:59:59+00:00"
generated_at: "2026-06-21T01:18:40.418534+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Director James T. LaFrance resigns from Aspira Women's Health board; Auerbach joins Audit Committee

## Summary
- James T. LaFrance resigned from the board of directors effective December 15, 2022.
- Dr. Robert Auerbach appointed to the Audit Committee following LaFrance's resignation.
- No reason for resignation disclosed in the filing.

## SEC filing metadata
- accession: 0000926617-22-000069
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2022-12-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000092661722000069/0000926617-22-000069-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000092661722000069/awh-20221215x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000926617-22-000069
- JSON: https://secwatch.observer/filing/0000926617-22-000069.json
- Plain text: https://secwatch.observer/filing/0000926617-22-000069.txt

## Key facts
- Executive change
  James T. LaFrance resigned as Director at Aspira Women's Health Inc..
  - Action: resigned
  - Role: Director
  source text: On December 15, 2022, James T. LaFrance resigned from the board of directors (the “ Board ”) of Aspira Women’s Health Inc., effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000092661722000069/0000926617-22-000069-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.